MedTrace Logo

Clinical Trial to Examine Individual Pain Tolerance in the Use of Two Anesthetic Techniques to Perform Saturation Prostate Biopsy

NCT02909049 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2018-01-26

No results posted yet for this study

Summary

To assess the effectiveness of two anesthetic techniques by measuring the pain through visual analog scale (VAS), to obtain saturation prostate biopsies.

Conditions

  • Prostatic Cancer

Interventions

DRUG

MIDAZOLAM

Intravenous bolus anesthesia 5 minutes previous to saturation prostate biopsy.

DRUG

MEPIVACAÍNE

Local periprostatic anesthesia infiltration, previous to saturation prostate biopsy.

DRUG

FENTANILE

Intravenous bolus anesthesia 3 minutes previous to saturation prostate biopsy.

DRUG

KETAMINE

Intravenous bolus anesthesia 1 minute previous to saturation prostate biopsy.

Sponsors & Collaborators

  • Complexo Hospitalario Universitario de A Coruña

    lead OTHER

Principal Investigators

  • Jose L Ponce, MD · Complejo Hospitalario Universitario, A Coruña

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-04-30
Primary Completion
2018-01-24
Completion
2018-01-24

Countries

  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02909049 on ClinicalTrials.gov